Long-term Dalbavancin for Suppression of Gram-Positive Chronic Left Ventricular Assist Device Infections

BACKGROUND: Infection is the leading cause of morbidity and mortality in patients with left ventricular assist devices (LVADs). Prolonged suppressive therapy should be strongly considered and is often used in patients with recurrent infections when source control cannot be achieved. Dalbavancin is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowe, Sarah, Green, Sarah, Albrecht, Benjamin, Pouch, Stephanie M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673638/
https://www.ncbi.nlm.nih.gov/pubmed/38023541
http://dx.doi.org/10.1093/ofid/ofad537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673638/
https://www.ncbi.nlm.nih.gov/pubmed/38023541
http://dx.doi.org/10.1093/ofid/ofad537

Ejemplares similares